CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity-Reference-Cited by-同舟云学术

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Published:2017-08-16 Issue:7670 Volume:549 Page:101-105
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Burr Marian L.,Sparbier Christina E.,Chan Yih-Chih,Williamson James C.,Woods Katherine,Beavis Paul A.,Lam Enid Y. N.,Henderson Melissa A.,Bell Charles C.,Stolzenburg Sabine,Gilan Omer,Bloor Stuart,Noori Tahereh,Morgens David W.,Bassik Michael C.,Neeson Paul J.,Behren Andreas,Darcy Phillip K.,Dawson Sarah-Jane,Voskoboinik Ilia,Trapani Joseph A.,Cebon Jonathan,Lehner Paul J.,Dawson Mark A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature23643.pdf

Reference19 articles.

1. Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56–61 (2015)

2. Boussiotis, V. A. Molecular and biochemical aspects of the PD-1 checkpoint pathway. N. Engl. J. Med. 375, 1767–1778 (2016)

3. Green, M. R. et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 116, 3268–3277 (2010)

4. Kataoka, K. et al. Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers. Nature 534, 402–406 (2016)

5. Morgens, D. W. et al. Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens. Nat. Commun. 8, 15178 (2017)

Cited by 663 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model;Archives of Oral Biology;2024-10

2. Parthenolide Inhibits Synthesis and Promotes Degradation of Programmed Cell Death Ligand 1 and Enhances T Cell Tumor-Killing Activity;Journal of Agricultural and Food Chemistry;2024-09-12

3. New Advances in the Study of CMTM6, a Focus on Its Novel Non-Canonical Cellular Locations, and Functions beyond Its Role as a PD-L1 Stabilizer;Cancers;2024-09-11

4. Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1;Advanced Science;2024-09-04

5. CMTM6 mediates the Warburg effect and promotes the liver metastasis of colorectal cancer;Experimental & Molecular Medicine;2024-09-02